东亚药业：第四届董事会第十次会议决议公告

Core Viewpoint - East Asia Pharmaceutical announced the approval of the proposal regarding the 2025 semi-annual report and its summary during the tenth meeting of the fourth board of directors [2] Group 1 - The company held its tenth meeting of the fourth board of directors on August 28 [2] - The meeting resulted in the approval of the proposal for the 2025 semi-annual report and its summary [2]